Methylation of the RASSF1A Gene in Human Cancers

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biological chemistry

• Publication date

  2002-06-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/BC.2002.097PMID 12222680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

  2002cited by this paper
• Identification of a novel Ras-regulated proapoptotic pathway.

  2002cited by this paper
• Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.

  2001cited by this paper
• Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma.

  2001cited by this paper
• Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene

  2001cited by this paper
• Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

  2001cited by this paper
• Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

  2001influential reference
• Wildtype Kras2 can inhibit lung carcinogenesis in mice

  2001cited by this paper
• RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

  2001cited by this paper
• Epigenetic Inactivation of the RASSF 1 A 3 p 21 . 3 Tumor Suppressor Gene in Both Clear Cell and Papillary Renal Cell Carcinoma 1

  2001influential reference
• Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.

  2001cited by this paper
• Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.

  2001influential reference
• Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies.

  2001cited by this paper
• Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

  2001cited by this paper
• The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis

  2001influential reference
• The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas

  2001cited by this paper
• Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.

  2001influential reference
• Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas

  2001cited by this paper
• High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.

  2001influential reference
• Role of chromosome 3p12–p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis

  2000cited by this paper
• Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis*

  2000cited by this paper
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

  2000cited by this paper
• Mutation hotspots and DNA methylation.

  2000cited by this paper
• The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.

  2000influential reference
• Inclusion of new microsatellite repeats in allelic loss analysis excludes retention of heterozygosity in the renal cell carcinoma critical region in 3p21.

  2000cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• Comparison of chromosome 3p deletions between cervical precancers synchronous with and without invasive cancer

  2000cited by this paper
• Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

  1999cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.

  1999cited by this paper
• Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members*

  1999cited by this paper
• Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene

  1998cited by this paper
• Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

  1998cited by this paper
• Ras signalling and apoptosis.

  1998cited by this paper
• The VHL tumour-suppressor gene paradigm.

  1998cited by this paper
• Microbial diversity of soda lakes

  1998cited by this paper
• Alterations in DNA methylation: a fundamental aspect of neoplasia.

  1998cited by this paper
• BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

  1998cited by this paper
• Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.

  1998cited by this paper
• Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.

  1998cited by this paper
• Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

  1998cited by this paper
• Identification of Nore1 as a Potential Ras Effector*

  1998influential reference
• Involvement of multiple loci on chromosome 3 in renal cell cancer development

  1997cited by this paper
• Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.

  1997influential reference
• The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21

  1997cited by this paper
• Homozygous deletions of human chromosome 3p in lung tumors.

  1997cited by this paper
• Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma.

  1997cited by this paper
• A novel family ofras-binding domains

  1996cited by this paper
• Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG.

  1996cited by this paper
• Isolation from a multigene family of the active human gene of the metastasis-associated multifunctional protein 37LRP/p40 at chromosome 3p21.3.

  1996cited by this paper
• The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer

  1996cited by this paper
• Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns.

  1996cited by this paper
• Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer.

  1996cited by this paper
• A novel family of Ras-binding domains.

  1996cited by this paper
• Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.

  1995cited by this paper
• Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.

  1995cited by this paper
• Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis.

  1995cited by this paper
• Gastric carcinoma.

  1995cited by this paper
• Protein Kinase C: Seeing two domains

  1995cited by this paper
• Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus.

  1995cited by this paper
• Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22.

  1993cited by this paper
• p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.

  1992cited by this paper
• Definition of a tumor suppressor locus within human chromosome 3p21-p22.

  1992cited by this paper
• High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines.

  1990cited by this paper
• De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines.

  1990cited by this paper
• CpG-rich islands and the function of DNA methylation

  1986cited by this paper

• Integrated genomic and epigenetic profiling reveals RAS pathway as a key driver of odontogenic tumors

  2025cites this paper
• Genome-Wide Methylation Patterns in Primary Uveal Melanoma: Development of MethylSig-UM, an Epigenomic Prognostic Signature to Improve Patient Stratification

  2024cites this paper
• Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells

  2023cites this paper
• Current understanding of epigenetics role in melanoma treatment and resistance

  2022cites this paper
• Spoken and Unspoken Matters Regarding the Use of Opioids in Cancer

  2022cites this paper
• Interaction of Thalassia testudinum Metabolites with Cytochrome P450 Enzymes and Its Effects on Benzo(a)pyrene-Induced Mutagenicity

  2020cites this paper
• Targeting Epigenetic Modifications in UM

  2020cites this paper
• Targeting Epigenetic Modifications in Uveal Melanoma

  2020cites this paper
• Association of Methylation of RASSF1A between Breast Cancer and Benign Breast Lesions: A Meta-Analysis

  2020cites this paper
• RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma

  2019cites this paper
• Association between methylation of RASSF1A and breast cancer: a meta-analysis

  2019cites this paper
• Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer

  2019cites this paper
• EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation

  2019cites this paper
• A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension

  2019cites this paper
• DNA Methylation and Uveal Melanoma

  2018cites this paper
• General discussion and future perspective

  2018cites this paper
• Clinical Utility of promoter methylation of the tumor suppressor genes DKK3, and RASSF1A in breast cancer patients

  2018cites this paper
• DNA methylation profiles in cancer diagnosis and therapeutics

  2018cites this paper
• Role of Epigenetics in Uveal Melanoma

  2017cites this paper
• The relationship between RASSF1A promoter methylation and thyroid carcinoma

  2017cites this paper
• The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics

  2017cites this paper
• Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.

  2016cites this paper
• β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients

  2016cites this paper
• Anti-inflammatory, epigenetic regulatory role of phytochemicals and pkpd modeling of pharmacological effects

  2016cites this paper
• Overexpression of methylation-driven DCC suppresses proliferation of lung cancer cells

  2016cites this paper
• Malignant Rhabdoid Tumors and Tumors with Rhabdoid Features

  2016cites this paper
• Dense RASSF1A methylation in uveal melanoma correlates with expression and clinical class

  2016cites this paper
• Epigenetic dysregulation in cadmium urothelial carcinogenesis

  2015cites this paper
• Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A.

  2015cites this paper
• Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection

  2015cites this paper
• RASSF6 promotes p21Cip1/Waf1-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma

  2014cites this paper
• Novel Therapeutic Approaches for Inflammatory Bowel disease

  2014cites this paper
• Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis

  2014cites this paper
• BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy

  2013cites this paper
• Predictive Biomarkers and Personalized Medicine Loss of NAPRT 1 Expression by Tumor-Speci fi c Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors

  2013cites this paper
• Genomewide DNA Methylation Analysis Identifies Novel Methylated Genes in Non–Small-Cell Lung Carcinomas

  2013cites this paper
• Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells

  2013cites this paper
• RASSF1A: a potential novel therapeutic target against cardiac hypertrophy.

  2013cites this paper
• Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors

  2013cites this paper
• Methylation of RASSF1A gene promoter is regulated by p53 and DAXX

  2013cites this paper
• Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma

  2013cites this paper
• INHIBITION OF LUNG TUMORIGENESIS AND CANCER CELL GROWTH BY EGCG AND OTHER CHEMOPREVENTIVE AGENTS by

  2013cites this paper
• Global and gene-specific promoter methylation analysis in primary hyperparathyroidism

  2013cites this paper
• The role of RASSF1A in uveal melanoma.

  2012cites this paper
• The cellular functions of RASSF1A and its inactivation in prostate cancer

  2012cites this paper
• Anatomy and Pathology The Role of RASSF 1 A in Uveal Melanoma

  2012cites this paper
• Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma

  2012cites this paper
• Genome-wide DNA methylation profiling of non-small cell lung carcinomas

  2012cites this paper
• Epigenetic Modifications in Testicular Germ Cell Tumors

  2012cites this paper
• Modulator of Apoptosis 1: A Highly Regulated RASSF1A-Interacting BH3-Like Protein

  2012cites this paper
• MOAP-1: A Candidate Tumor Suppressor Protein

  2012cites this paper
• DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma

  2011cites this paper
• Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression

  2011cites this paper
• Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma

  2011cites this paper
• RASSF1A hypermethylation is associated with aflatoxin B1 and polycyclic aromatic hydrocarbon exposure in hepatocellular carcinoma.

  2011cites this paper
• Frequent and Distinct Aberrations of DNA Methylation Patterns in Fibrolamellar Carcinoma of the Liver

  2010cites this paper
• BESCT (Biology, Education, Screening, Chemoprevention and Treatment) Program

  2010cites this paper
• DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers

  2009influential citation
• is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers

  2009influential citation
• Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.

  2008cites this paper
• Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II

  2008cites this paper
• Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.

  2008cites this paper
• Synergy of DNA methylation and histone deacetylase inhibitors in the re-expression of RASSF1A and P16 genes silenced in QBC cells

  2008cites this paper
• Putative association of the single nucleotide polymorphisms in RASSF1A promoter with Korean lung cancer.

  2008cites this paper
• Epigenetic markers of ovarian cancer.

  2008cites this paper
• Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells.

  2007cites this paper
• The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network

  2007cites this paper
• Promoter methylation status of multiple genes in uveal melanoma.

  2007cites this paper
• RASSF1A promoter methylation is frequently detected in both pre‐malignant and non‐malignant microdissected prostatic epithelial tissues

  2007cites this paper
• RASSF6 is a novel member of the RASSF family of tumor suppressors

  2007cites this paper
• Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals.

  2007cites this paper
• Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.

  2006cites this paper
• Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC‐7721

  2006cites this paper
• Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver

  2006cites this paper
• The Drosophila RASSF Homolog Antagonizes the Hippo Pathway

  2006cites this paper
• Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk.

  2006cites this paper
• Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.

  2006cites this paper
• Knowledge of epigenetic influence for prostate cancer therapy.

  2006cites this paper
• Growth inhibitory effects of quercetin on bladder cancer cell.

  2006cites this paper
• RASSF family proteins and Ras transformation.

  2006cites this paper
• DNA methylation profiles of female steroid hormone-driven human malignancies.

  2006cites this paper
• Effectors of Ras-Mediated Oncogenesis

  2006cites this paper
• The RASSF1A Isoform of RASSF1 Promotes Microtubule Stability and Suppresses Tumorigenesis

  2005cites this paper
• Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis.

  2005cites this paper
• A methylation profile of in vitro immortalized human cell lines.

  2005cites this paper
• A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast.

  2005cites this paper
• Oncogenes and Tumor Suppressor Genes in Malignant Mesothelioma

  2005cites this paper
• Signaling properties and expression in normal and tumor tissues of two phospholipase C epsilon splice variants

  2005cites this paper
• Aberrant DNA methylation in cutaneous malignancies.

  2005cites this paper
• Tumor susceptibility of Rassf1a knockout mice.

  2005cites this paper
• Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer

  2005cites this paper
• Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma

  2005cites this paper
• Aberrant methylation of the negative regulators RASSFIA, SHP‐1 and SOCS‐1 in myelodysplastic syndromes and acute myeloid leukaemia

  2005cites this paper
• Genomic alterations in cultured human embryonic stem cells

  2005cites this paper
• BRAF mutation in thyroid cancer.

  2005cites this paper
• Review The tumor suppressor RASSF1A in human carcinogenesis: an update

  2005cites this paper
• RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer

  2005cites this paper
• The tumor suppressor RASSF1A in human carcinogenesis: an update.

  2005cites this paper
• Methylation of the Tumor Suppressor Gene RASSF1A in Human Tumors

  2005cites this paper
• High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma

  2005cites this paper